Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Beyond Type 1's CrossCountry "Bike Beyond" Program To Kick Off On June 3rd, 2017
Toggle Summary Insulet Appoints Bret Christensen as Chief Commercial Officer
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced the appointment of Bret Christensen as Chief Commercial Officer. Mr.
View HTML
Toggle Summary Insulet Corporation Ranked #4 on Forbes 2017 Most Innovative Growth Companies List
Leader in Tubeless Insulin Pump Technology Ranks in Top Five Percent Among List of Most Innovative 100 Public Companies BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation  (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ®  Insulin
View HTML
Toggle Summary Insulet Reports First Quarter 2017 Financial Results
First Quarter Revenue of $101.7 Million , up 25% Year-Over-Year, Exceeds Expectations Gross Margin Improves to 58.4% Insulet Raises Mid-Point of Full Year 2017 Revenue Guidance, Expecting Growth of 18%, and Introduces Second Quarter Growth Expectation of 21% BILLERICA, Mass.
View HTML
Toggle Summary Insulet Corporation to Announce First Quarter 2017 Financial Results on May 8, 2017
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the first quarter 2017 on May 8, 2017 after the
View HTML
Toggle Summary Insulet Reports Fourth Quarter and Full Year 2016 Financial Results
Fourth Quarter Revenue of $103.6 Million , up 24% Year-Over-Year; Full Year 2016 Revenue of $367.0 Million , up 39% Year-Over Year, Exceeds Expectations Fourth Quarter Gross Margin Improves to 58.8%; Full Year 2016 Gross Margin Improves to 57.5% Insulet Expects Full Year 2017 Revenue Growth of
View HTML
Toggle Summary Insulet Presents Strong Omnipod® Horizon™ Hybrid Closed-Loop Study Results at ATTD in Paris
First Feasibility Study on the Automated Glucose Control Algorithm Demonstrates Beneficial Results in Adults with Type 1 Diabetes BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation  (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ®
View HTML
Toggle Summary Insulet Completes Acquisition of U.S. Manufacturing Facility in Acton, Massachusetts
Facility to Support Long-Term Growth Initiatives While Driving Increased Productivity and Quality BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today
View HTML
Toggle Summary Insulet Corporation to Present at Upcoming Investor Conferences
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at two upcoming investor conferences: The Cowen and Company
View HTML
Toggle Summary Insulet Corporation to Announce Fourth Quarter and Full Year 2016 Financial Results on February 27, 2017
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the fourth quarter and full year 2016
View HTML
Toggle Summary Insulet Corporation to Present at Upcoming Investor Conference
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation ( NASDAQ : PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at the 35 th Annual J.P.
View HTML
Toggle Summary Insulet Celebrates Milestone of 100,000 Customers Actively Using the Omnipod® System
During National Diabetes Awareness Month, Insulet honors Omnipod users and reinforces commitment to help make living with diabetes easier BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation ( NASDAQ : PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its
View HTML
Toggle Summary Insulet to Webcast Investor Day on November 16, 2016
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation ( NASDAQ : PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced it will host an Investor Day on November 16, 2016 , in Boston, Massachusetts .
View HTML
Toggle Summary Insulet Reports Third Quarter 2016 Financial Results
Third Quarter Revenue of $94.9 Million , up 33% Year-Over-Year, Exceeds Expectations Gross Margin Improves to 58.6% Company Raises Full Year 2016 Revenue Guidance to a Range of $362 to $365 million , from $345 to $355 million ; Approximately 38% Year-Over-Year Growth at Mid-Point BILLERICA, Mass.
View HTML
Toggle Summary New Study Shows Majority of Omnipod® Insulin Management System Users Report Significant Clinical and Quality of Life Benefits
Data Published in Diabetes Technology & Therapeutics Demonstrates Improved A1c Levels, Patients' Well-Being, and Perceived Control over Diabetes BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation ( NASDAQ : PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with
View HTML